KIR3DL2 and ischemic stroke: Although it is already known that ischemic stroke subtypes are associated with different prognoses and that AIS patients show a specific HLA and killer cell immunoglobulin-like receptor (KIR) genotyping [12,13], this different expression of both miRNAs may suggest their role as biomarkers of brain tissue damage severity.